Proopiomelanocortin peptides are not essential for development of ethanol-induced behavioral sensitization.

BACKGROUND Behavioral sensitization is a result of neuroadaptation to repeated drug administration and is hypothesized to reflect an increased susceptibility to drug abuse. Proopiomelanocortin (POMC) derived peptides including beta-endorphin and alpha-melanocyte stimulating hormone have been implicated in development of behavioral sensitization and the reinforcing effects of alcohol and other drugs of abuse. This study used a genetically engineered mouse strain that is deficient for neural POMC to directly determine if any POMC peptides are necessary for the development of ethanol-induced locomotor sensitization. METHODS Adult female mice deficient for POMC in neurons only (Pomc(-/-)Tg/Tg, KO) and wildtype (Pomc(+/+)Tg/Tg, WT) littermates were injected once daily with either saline or ethanol (i.p.) for 12 to 13 days. On ethanol test day (day 13 or 14) all mice from both treatment groups received an i.p. injection of ethanol immediately before a 15-minute analysis of locomotor activity. Blood ethanol concentration (BEC) was measured on ethanol test day immediately following the test session. Baseline locomotor activity was measured for 15 minutes after a saline injection 2 days later in both groups. RESULTS There was no significant difference in BEC between genotypes (WT = 2.11 +/- 0.06; KO = 2.03 +/- 0.08 mg/ml). Both WT and nPOMC-deficient mice treated repeatedly with ethanol demonstrated a significant increase in locomotor activity on test day when compared to repeated saline-treated counterparts. In addition, mice of both genotypes in the repeated saline groups showed a significant locomotor stimulant response to acute ethanol injection. CONCLUSIONS Central POMC peptides are not required for either the acute locomotor stimulatory effect of ethanol or the development of ethanol-induced locomotor sensitization. While these peptides may modulate other ethanol-associated behaviors, they are not essential for development of behavioral sensitization.

[1]  J. Crabbe,et al.  Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). , 2007, Alcoholism, clinical and experimental research.

[2]  M. Low,et al.  Central dysregulation of the hypothalamic-pituitary-adrenal axis in neuron-specific proopiomelanocortin-deficient mice. , 2007, Endocrinology.

[3]  U. Gómez-Pinedo,et al.  Effects of estradiol valerate on voluntary alcohol consumption, β-endorphin content and neuronal population in hypothalamic arcuate nucleus , 2006, Pharmacology Biochemistry and Behavior.

[4]  C. Aragon,et al.  The Role of Opioid Receptor Subtypes in the Development of Behavioral Sensitization to Ethanol , 2006, Neuropsychopharmacology.

[5]  M. Low,et al.  Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. , 2006, The Journal of clinical investigation.

[6]  G. Breese,et al.  Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. , 2005, Alcoholism, clinical and experimental research.

[7]  JaneR . Taylor,et al.  Blockade of melanocortin transmission inhibits cocaine reward , 2005, The European journal of neuroscience.

[8]  M. Low,et al.  Operant self-administration of ethanol in C57BL/6 mice lacking β-endorphin and enkephalin , 2004, Pharmacology Biochemistry and Behavior.

[9]  M. Miquel,et al.  Neonatal administration of monosodium glutamate prevents the development of ethanol‐ but not psychostimulant‐induced sensitization: a putative role of the arcuate nucleus , 2003, The European journal of neuroscience.

[10]  R. Quirion,et al.  Estradiol valerate and alcohol intake: a comparison between Wistar and Lewis rats and the putative role of endorphins , 2003, Behavioural Brain Research.

[11]  H. Schiöth,et al.  Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats , 2002, Brain Research Bulletin.

[12]  C. Sanchis-Segura,et al.  Consequences of monosodium glutamate or goldthioglucose arcuate nucleus lesions on ethanol-induced locomotion. , 2002, Drug and alcohol dependence.

[13]  A. Kelley,et al.  Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens , 2002, Psychopharmacology.

[14]  C. Hodge,et al.  Stimulation of Endorphin Neurotransmission in the Nucleus Accumbens by Ethanol, Cocaine, and Amphetamine , 2001, The Journal of Neuroscience.

[15]  K. Berridge,et al.  Incentive-sensitization and addiction. , 2001, Addiction.

[16]  M. Correa,et al.  Lession on the hypothalamic arcuate nucleus by estradiol valerate results in a blockade of ethanol-induced locomotion , 2000, Behavioural Brain Research.

[17]  H. Kalant.  Effects of food and body composition on blood alcohol curves. , 2000, Alcoholism, clinical and experimental research.

[18]  R. Blouin,et al.  Pharmacokinetic considerations in obesity. , 1999, Journal of pharmaceutical sciences.

[19]  E. Fitzhugh,et al.  Acute alcohol intoxication, body composition, and pharmacokinetics , 1992, Pharmacology Biochemistry and Behavior.

[20]  C. Cunningham,et al.  Conditioned activation induced by ethanol: Role in sensitization and conditioned place preference , 1992, Pharmacology Biochemistry and Behavior.

[21]  W. Banks,et al.  Peptide transport systems for opiates across the blood-brain barrier. , 1990, The American journal of physiology.

[22]  M. L. Souza,et al.  The excitatory effect of ethanol: Absence in rats, no tolerance and increased sensitivity in mice , 1986, Pharmacology Biochemistry and Behavior.

[23]  J. Crabbe,et al.  Neonatal monosodium glutamate lesions alter neurosensitivity to ethanol in adult mice , 1986, Pharmacology Biochemistry and Behavior.

[24]  R. Post,et al.  Increasing effects of repetitive cocaine administration in the rat , 1976, Nature.

[25]  D. Segal,et al.  Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. , 1974, Pharmacology, biochemistry, and behavior.

[26]  W. M. Davis,et al.  Time‐dose relationships for locomotor activity effects of morphine after acute or repeated treatment , 1972, British journal of pharmacology.

[27]  K. Gundersen,et al.  Total body water in obesity. , 1966, The American journal of clinical nutrition.